Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Boyd Steven
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   47,075,098    

Indirect Shares

   40,287,245      
Direct Value   $128,455,406    

Indirect Value

   $40,265,984      
Total Shares   87,362,343      
Total Value   $168,721,391      


Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407 Avalo Therapeutics, Inc $14,783 Dynatronics Corp $233,800 Kiora Pharmaceuticals $625,814 Fresh Tracks Therapeutics Ord Shs $1,466,920 Alimera Sciences Inc $2,115,480 Cassava Sciences Inc $36,379,020 Bio-Path Holdings, Inc. $46,806 AYTU BIOSCIENCE, INC $4,228,491 Achieve Life Sciences Inc $4,404,511 AMAG Pharmaceuticals Inc $56,650,000 Onconova Therapeutics, Inc. $596,192 Vaxart Inc $118,601 Tenax Therapeutics Inc $524,997 Cyclo Therapeutics, Inc $20,218,584 ReShape Lifesciences Inc $831,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    99   
    96    

     Stock price went up :
    54   
    46    
     Stock price went down :
    45   
    50    
   
     Gain/Loss Ratio :
   1.2   
   1.2   
     Percentage Gain/Loss :
   -16.7%
 8,928.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avalo Therapeutics, Inc AVTX 10% Owner 2023-06-27 34,370 2023-06-27 731,458    Premium*  
            Dynatronics Corp DYNT 10% Owner 2017-03-21 500,000 2017-03-21 1,000,000    Premium*  
            Kiora Pharmaceuticals KPRX 10% Owner 2021-01-06 3,346,601 2021-08-02 785,000    Premium*  
            Fresh Tracks Therapeutics Ord Shs FRTX 10% Owner 2019-01-10 2,170,000 2019-01-10 2,170,000    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2018-02-06 6,936,000 2018-02-06 6,936,000    Premium*  
            Cassava Sciences Inc SAVA 10% Owner 2018-10-03 1,651,340 2018-10-03 0    Premium*  
            Del Friscos Restaurant Group, Llc DFRG 10% Owner 2019-09-25 0 2019-09-25 0    Premium*  
            Valeritas Holdings Inc VLRX 10% Owner 2019-12-20 0 2019-12-20 0    Premium*  
            Bio-Path Holdings, Inc. BPTH 10% Owner 2019-01-18 129,298 2019-01-18 129,298    Premium*  
            AYTU BIOSCIENCE, INC AYTU Director 2021-03-29 1,342,378 2021-03-29 1,342,378    Premium*  
            Achieve Life Sciences Inc ACHV 10% Owner 2019-06-11 843,776 2019-06-11 843,776    Premium*  
            AMAG Pharmaceuticals Inc AMAG 10% Owner 2020-03-16 4,120,000 2020-03-16 348,000    Premium*  
            Onconova Therapeutics, Inc. ONTX 10% Owner 2019-09-23 816,702 2019-09-23 816,702    Premium*  
            Vaxart Inc VXRT Director 2020-06-29 145,523 2020-06-29 145,523    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director, 10% Owner 2020-07-28 0 2020-07-28 0    Premium*  
            Tenax Therapeutics Inc TENX Director, 10% Owner 2020-09-08 2,019,995 2020-09-08 2,019,995    Premium*  
            Cyclo Therapeutics, Inc CYTH 10% Owner 2020-09-30 15,795,769 2020-09-30 15,795,769    Premium*  
            ReShape Lifesciences Inc RSLS 10% Owner 2021-06-28 7,223,346 2021-06-28 7,223,346    Premium*  
* Premium Members only  

Records found :    790         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 31 of 32
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-28 4 OE $0.00 $0 D/D 7,130,806 7,223,346 0 -
RSLS ReShape Lifesciences Inc 10% Owner   –       –       •   2021-06-28 4 OE $0.00 $0 I/I 0 7,223,346 0 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-27 4 S $3.80 $12,113,647 I/I (2,377,695) 1,821,406 0 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-27 4 OE $4.80 $4,092,000 I/I 852,500 4,199,101 0 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-28 4 S $3.28 $1,232,617 I/I (375,443) 1,445,963 0 -
KPRX Kiora Pharmaceuticals Director   –       •       •   2021-07-29 4 S $3.00 $1,200,000 I/I (400,000) 1,045,963 0 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-07-30 4 S $2.69 $183,562 I/I (68,188) 977,775 0 -
KPRX Kiora Pharmaceuticals 10% Owner   –       –       •   2021-08-02 4 S $2.40 $463,046 I/I (192,775) 785,000 0 -
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-04 4 B $2.69 $268,590 I/I 100,000 39,200,000 1.5 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-05 4 B $2.77 $69,295 I/I 25,000 39,225,000 1.5 %
AVTX Avalo Therapeutics, Inc 10% Owner   –       –       •   2021-08-06 4 B $2.83 $70,630 I/I 25,000 39,250,000 1.5 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-08-16 4 B $2.75 $82,638 I/I 30,000 39,280,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-08-18 4 B $2.78 $55,550 I/I 20,000 39,300,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-09-15 4 B $2.26 $215,948 I/I 95,455 39,395,455 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-09-16 4 B $2.28 $341,955 I/I 150,000 39,545,455 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2021-09-17 4 B $2.20 $11,999,999 I/I 5,454,545 45,000,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-07 4 B $1.04 $142,975 I/I 137,900 45,137,900 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-10 4 B $0.99 $484,615 I/I 491,097 45,628,997 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-11 4 B $0.96 $15,342 I/I 16,003 45,645,000 2.17 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-12 4 B $1.04 $59,781 I/I 57,300 45,702,300 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-13 4 B $1.00 $314,013 I/I 312,700 46,015,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-14 4 B $0.93 $78,974 I/I 85,000 46,100,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-18 4 B $0.88 $182,225 I/I 206,300 46,306,300 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-19 4 B $0.88 $82,053 I/I 93,700 46,400,000 2.25 %
AVTX Avalo Therapeutics, Inc Director   –       •       •   2022-01-20 4 B $0.85 $10,208 I/I 12,000 46,412,000 2.17 %
  790  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31  32      
  Page 31 of 32  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us